Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway
Abstract Purpose Recent studies have revealed an increase in the incidence rate of non-alcoholic fatty liver disease-related hepatocellular carcinoma (NAFLD-HCC). Furthermore, the association of Sphingosine 1-phosphate receptor 2 (S1PR2) with various types of tumours is identified, and the metabolis...
Main Authors: | Ganggang Wang, Xin Zhang, Zhijie Zhou, Chao Song, Wenzhi Jin, Hao Zhang, Weixin Wu, Yong Yi, Hengguan Cui, Ping Zhang, Xinyu Liu, Weiqiang Xu, Xiaowei Shen, Weixing Shen, Xiaoliang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2023-01-01
|
Series: | Discover Oncology |
Online Access: | https://doi.org/10.1007/s12672-023-00611-8 |
Similar Items
-
To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway
by: Jiateng Zhong, et al.
Published: (2023-02-01) -
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01) -
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
by: Stefano Ratti, et al.
Published: (2022-02-01) -
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
by: Eun Jin Sun, et al.
Published: (2021-11-01) -
The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
by: Tasuku Matsuoka, et al.
Published: (2014-07-01)